Reactions Weekly

, Volume 1696, Issue 1, pp 333–333 | Cite as

Sorafenib

Liver toxicity and aggravation of chronic graft versus host disease: 2 case reports
Case report
  • 11 Downloads

Reference

  1. Lange A, et al. The mechanism of sorafenib anti-leukaemic effect seen in AML patients relapsing post alloHSCT involves the augmentation of alloreactivity which includes infiltration of the affected marrow by CD8+ cells having PD-1 receptor which presence characterize lymphocytes with anti-tumour potential. Bone Marrow Transplantation 52 (Suppl. 1): 254 abstr. B240, 2017. Available from: URL: http://cme-utilities.com/mailshotcme/Abstracts/Poster/Physicians%20Poster%20Abstracts%20Day%202%20120317.pdf [abstract] -Poland

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations